Cellectar Biosciences
Price & Volume
Stats
See more52W Range | $2.71-$50.70 |
Market Cap | $12.3M |
Shares Short | 266,511 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$8.07 |
News
See moreYahoo Finance • 5 days ago
Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Yahoo Finance • 12 days ago
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025
Yahoo Finance • last month
Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research
Yahoo Finance • last month
Cellectar Biosciences Stock Rises Over EMA's Advise On CMA Filing For Iopofosine I 131
About
CEO | Mr. James V. Caruso |
CFO | Mr. Chad J. Kolean CPA |
Address | 100 Campus Drive, Florham Park, NJ, United States, 07932 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11 |
